Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLS Apellis Pharmaceuticals Inc.

未开盘 04-30 16:00:00 EDT

19.21

+1.00

+5.49%

盘后18.84

-0.37-1.91%

18:47 EDT

最高19.21	最低17.76	成交量262.67万
今开18.14	昨收18.21	日振幅7.96%
总市值24.14亿	流通市值16.20亿	总股本1.26亿
成交额4,925万	换手率3.11%	流通股本8,434万
市净率10.56	ROE-93.55%	每股收益-1.60
52周最高49.06	52周最低16.98	市盈率-12.03
股息0.00	股息收益率0.00	ROA-12.32%

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLS","market":"US","secType":"STK","nameCN":"Apellis Pharmaceuticals Inc.","latestPrice":19.21,"timestamp":1746043200000,"preClose":18.21,"halted":0,"volume":2626711,"hourTrading":{"tag":"盘后","latestPrice":18.8432,"preClose":19.21,"latestTime":"18:47 EDT","volume":19668,"amount":377786.56,"timestamp":1746053273685},"delay":0,"floatShares":84335561,"shares":125682260,"eps":-1.597013,"marketStatus":"未开盘","change":1,"latestTime":"04-30 16:00:00 EDT","open":18.14,"high":19.21,"low":17.76,"amount":49246678.41990899,"amplitude":0.079627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.597013,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1510203600000,"exchange":"NASDAQ","adjPreClose":18.21,"preHourTrading":{"tag":"盘前","latestPrice":18.2,"preClose":18.21,"latestTime":"09:28 EDT","volume":540,"amount":9845.844840000002,"timestamp":1746019680073},"postHourTrading":{"tag":"盘后","latestPrice":18.8432,"preClose":19.21,"latestTime":"18:47 EDT","volume":19668,"amount":377786.56,"timestamp":1746053273685},"volumeRatio":1.137441,"optionData":{"bulkOrders":[{"symbol":"APLS","call":true,"expireDate":1768539600000,"strike":"40.0","timestamp":1746037854370,"price":0.36,"volume":10000,"amount":360000,"type":"-"},{"symbol":"APLS","call":true,"expireDate":1768539600000,"strike":"20.0","timestamp":1746037854371,"price":4.24,"volume":5000,"amount":2120000,"type":"-"}]},"impliedVol":0.7891,"impliedVolPercentile":0.804},"requestUrl":"/m/hq/s/APLS","defaultTab":"news","newsList":[{"id":"2532086062","title":"Apellis Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532086062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532086062?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:46","pubTimestamp":1746038776,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时46分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.00%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物， 通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501024616a6cf2ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501024616a6cf2ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","BK4505","LU1093756325.SGD","LU1093756168.USD","APLS"],"gpt_icon":0},{"id":"2529620680","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529620680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529620680?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:11","pubTimestamp":1745417515,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时11分，Apellis Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.07%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物， 通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221155a46404a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221155a46404a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","APLS","LU1093756168.USD","BK4585","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2529383473","title":"加拿大皇家银行：维持Apellis Pharmaceuticals(APLS.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由24.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383473","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529383473?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:43","pubTimestamp":1745253791,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Apellis Pharmaceuticals(APLS.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由24.00美元调整至21.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22004349732258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["APLS"],"gpt_icon":0},{"id":"2518428998","title":"Apellis Pharmaceuticals, Inc.2024财年实现净利润-1.98亿美元，同比增加62.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518428998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518428998?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449653,"startTime":"0","endTime":"0","summary":"3月9日，Apellis Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.98亿美元，同比增加62.57%；其中营业收入为7.81亿美元，同比增加96.73%，每股基本收益为-1.60美元。从资产负债表来看，Apellis Pharmaceuticals, Inc.总负债6.57亿美元，其中短期债务6.75百万美元，资产负债比为1.35，流动比率为4.25。机构评级：截至2025年3月9日，当前有20家机构对Apellis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为43.60美元，其中最低目标价为25.00美元，最高目标价为75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000207abef97bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000207abef97bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS"],"gpt_icon":0},{"id":"1130319973","title":"异动解读 | 生物技术公司Apellis Pharmaceuticals股价盘中大涨5.26%,业绩数据和机构看好预期或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1130319973","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130319973?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:46","pubTimestamp":1741117592,"startTime":"0","endTime":"0","summary":"APLS在2025年3月4日周二盘中出现大涨5.26%的行情,引发了市场广泛关注。\n\n分析人士认为,可能是该公司最新财报数据令投资者对其长期前景看好所致。财报显示,公司去年实现营收7.81亿美元,虽然净利润略为负数,但在生物技术行业中表现尚可。同时大部分机构给予该股买入或持有评级,认为其在新药研发领域具备较强实力。\n\nAPLS是一家商业化阶段的生物制药公司,专注于免疫系统中补体反应通路相关疾病的新药研发。行业分析人士认为,公司在补体领域的技术储备较为丰富,若能顺利推出有突破性的产品,长期前景值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 生物技术公司Apellis Pharmaceuticals股价盘中大涨5.26%,业绩数据和机构看好预期或是主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"2517798801","title":"Apellis Pharmaceuticals, Inc.盘中异动 大幅拉升5.03%报25.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517798801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517798801?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:36","pubTimestamp":1741117017,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时36分，Apellis Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.03%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033657a25f58e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033657a25f58e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","APLS","BK4588","LU1093756325.SGD","LU1093756168.USD","BK4505","BK4139"],"gpt_icon":0},{"id":"1192955750","title":"异动解读 | 投行下调目标价致使Apellis Pharmaceuticals盘中股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192955750","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192955750?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:16","pubTimestamp":1741025814,"startTime":"0","endTime":"0","summary":"生物科技公司Apellis Pharmaceuticals(APLS)今日盘中股价大幅下挫,引发市场密切关注。\n\n投行高盛(GS)下调了该公司的股票目标价,成为该股大跌的主要推手。高盛将Apellis Pharmaceuticals的目标价由之前的36美元下调至32美元,但维持中性投资评级不变。\n\n作为分析师报告下调目标价的主要原因尚未透露,但投资者担心公司增长前景或盈利能力未达预期,导致股票遭到抛售。Apellis Pharmaceuticals盘中一度下跌逾5%,市值蒸发数亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 投行下调目标价致使Apellis Pharmaceuticals盘中股价大跌5.05%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"2516365458","title":"Apellis Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.09%报23.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516365458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516365458?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:13","pubTimestamp":1741025601,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时13分，Apellis Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.09%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021322abe6743e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021322abe6743e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","LU1093756325.SGD","BK4505","APLS","LU1093756168.USD"],"gpt_icon":0},{"id":"2516632237","title":"高盛：维持Apellis Pharmaceuticals(APLS.US)评级，由中性调整至中性评级, 目标价由36.00美元调整至32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632237","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632237?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:54","pubTimestamp":1741013661,"startTime":"0","endTime":"0","summary":"高盛：维持Apellis Pharmaceuticals(APLS.US)评级，由中性调整至中性评级, 目标价由36.00美元调整至32.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03225448494325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["APLS"],"gpt_icon":0},{"id":"1157137146","title":"异动解读 | Apellis Pharmaceuticals Inc.盘中大跌5.31%,第四季度业绩表现不佳仍未如市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1157137146","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157137146?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:48","pubTimestamp":1740754119,"startTime":"0","endTime":"0","summary":"生物制药公司Apellis Pharmaceuticals Inc. 今日盘中股价大跌5.31%,主要原因是该公司第四季度的业绩虽然超过了去年同期,但仍未达到分析师预期。\n\n财报显示,Apellis上季度每股亏损29美分,营收同比增长45.2%至2.13亿美元。虽然营收数据超过了分析师预期,但亏损程度高于分析师此前的预期每股亏损39美分。\n\n其股价走势也引发了市场担忧,本季度股价下跌了18.5%。华尔街分析师给出的12个月目标价仍为46美元,但分析师近期对其盈利预期连续两次下调,体现出对该公司未来增长前景的担忧。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"2514201153","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201153?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753263,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Apellis Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.12%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223423abe0eb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223423abe0eb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","APLS","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"1193402188","title":"异动解读 | Apellis Pharmaceuticals Inc. (APLS) 盘前大涨9.62%,2024年Q4财报超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1193402188","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193402188?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:16","pubTimestamp":1740744986,"startTime":"0","endTime":"0","summary":"生物制药公司Apellis Pharmaceuticals Inc. (APLS)今日盘前交易中大涨9.62%,引发市场关注。\n公司此前公布的2024年第四季度财报数据显示,其每股亏损为0.29美元,优于分析师预期的0.37美元;季度销售额2.1253亿美元,也超过了分析师预期的1.9835亿美元。\n出色的财报业绩提振了投资者信心,令公司股价在盘前交易中大涨。市场预计Apellis Pharmaceuticals未来业绩或将持续向好,公司在生物医药领域的前景备受看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"1181385339","title":"Apellis Pharmaceuticals 2024年第四季度GAAP每股收益$(0.29)优于预期$(0.37)，销售额$2.1253亿优于预期$1.9835亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1181385339","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181385339?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:15","pubTimestamp":1740744917,"startTime":"0","endTime":"0","summary":"Apellis Pharmaceuticals报告的季度每股亏损为$，比分析师的共识预期$高出21.62%。这是与去年同期销售额1.4638亿美元相比增加了45.19%。以上内容来自Benzinga Earnings专栏，原文如下：Apellis Pharmaceuticals  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 21.62 percent. This is a 60.27 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $212.53 million which beat the analyst consensus estimate of $198.35 million by 7.15 percent.  This is a 45.19 percent i","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apellis Pharmaceuticals 2024年第四季度GAAP每股收益$(0.29)优于预期$(0.37)，销售额$2.1253亿优于预期$1.9835亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLS"],"gpt_icon":0},{"id":"2511521774","title":"Apellis Pharmaceuticals, Inc.盘中异动 快速跳水5.09%报27.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511521774?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:27","pubTimestamp":1739460469,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时27分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报27.06美元/股，成交量22.8697万股，换手率0.18%，振幅5.58%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232749a244b78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232749a244b78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","APLS","BK4585","BK4505","BK4588","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2503447647","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%报29.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503447647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503447647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:38","pubTimestamp":1736951910,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时38分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.00%。截至发稿，该股报29.08美元/股，成交量11.874万股，换手率0.10%，振幅3.29%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152238309604b607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152238309604b607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","LU1093756325.SGD","LU1093756168.USD","APLS","BK4139","BK4585"],"gpt_icon":0},{"id":"2502673658","title":"Apellis Pharmaceuticals, Inc.盘中异动 急速下挫9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502673658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502673658?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:30","pubTimestamp":1736519438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时30分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速跳水9.09%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102230389861e756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102230389861e756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","APLS","BK4585","BK4505","BK4588","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2501126990","title":"Apellis Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.02%报35.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501126990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501126990?lang=zh_cn&edition=full","pubTime":"2025-01-07 03:19","pubTimestamp":1736191152,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日03时19分，Apellis Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.02%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107031912a217d212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107031912a217d212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU1093756325.SGD","BK4585","BK4588","LU1093756168.USD","BK4139","APLS"],"gpt_icon":0},{"id":"2490706217","title":"Apellis Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报35.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490706217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490706217?lang=zh_cn&edition=full","pubTime":"2024-12-10 02:16","pubTimestamp":1733768167,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日02时16分，Apellis Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.02%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210021607984ace09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210021607984ace09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","APLS","LU1093756168.USD","BK4585","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2485414473","title":"Apellis Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.07%报27.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485414473","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485414473?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:40","pubTimestamp":1732120835,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时40分，Apellis Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报27.52美元/股，成交量86.8153万股，换手率0.70%，振幅4.78%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004035abd26c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004035abd26c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1093756168.USD","APLS","BK4139","BK4585","LU1093756325.SGD","BK4505"],"gpt_icon":0},{"id":"2484289019","title":"Apellis Pharmaceuticals, Inc.盘中异动 股价大涨8.98%报28.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484289019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484289019?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026682,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分，Apellis Pharmaceuticals, Inc.股票出现波动，股价大幅拉升8.98%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922312295be4a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922312295be4a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","APLS","LU1093756325.SGD","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apellis.com","stockEarnings":[{"period":"1week","weight":0.0983},{"period":"1month","weight":-0.1216},{"period":"3month","weight":-0.3679},{"period":"6month","weight":-0.3134},{"period":"1year","weight":-0.5653},{"period":"ytd","weight":-0.398}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apellis Pharmaceuticals, Inc.于2009年9月25日根据德拉华州法律成立。该公司是一家商业阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过在补体级联中的中心蛋白C3水平上抑制补体系统（作为免疫系统的一个组成部分）来治疗具有高度未满足需求的疾病。2023年2月，美国食品药品监督管理局（FDA）批准了SYFOVRE，这是首个获批治疗继发于年龄相关性黄斑变性（GA）的地理萎缩的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0274},{"month":2,"riseRate":0.625,"avgChangeRate":0.032574},{"month":3,"riseRate":0.5,"avgChangeRate":0.022263},{"month":4,"riseRate":0.625,"avgChangeRate":0.039768},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.025158},{"month":6,"riseRate":0.714286,"avgChangeRate":0.080149},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.099521},{"month":8,"riseRate":0.857143,"avgChangeRate":0.144378},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.143331},{"month":10,"riseRate":0.428571,"avgChangeRate":0.015269},{"month":11,"riseRate":0.714286,"avgChangeRate":0.147845},{"month":12,"riseRate":0.75,"avgChangeRate":0.124183}],"exchange":"NASDAQ","name":"Apellis Pharmaceuticals Inc.","nameEN":"Apellis Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apellis Pharmaceuticals Inc.,APLS,Apellis Pharmaceuticals Inc.股票,Apellis Pharmaceuticals Inc.股票老虎,Apellis Pharmaceuticals Inc.股票老虎国际,Apellis Pharmaceuticals Inc.行情,Apellis Pharmaceuticals Inc.股票行情,Apellis Pharmaceuticals Inc.股价,Apellis Pharmaceuticals Inc.股市,Apellis Pharmaceuticals Inc.股票价格,Apellis Pharmaceuticals Inc.股票交易,Apellis Pharmaceuticals Inc.股票购买,Apellis Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}